相似文献
1
Preoperative Assessment of Cancer Patients with Peritoneal Metastases for Complete Cytoreduction.
Indian J Surg Oncol. 2016 Sep;7(3):295-302. doi: 10.1007/s13193-016-0518-0. Epub 2016 Mar 11.
2
Assessment of peritoneal metastases with DW-MRI, CT, and FDG PET/CT before cytoreductive surgery for advanced stage epithelial ovarian cancer.
Eur J Surg Oncol. 2021 Aug;47(8):2134-2141. doi: 10.1016/j.ejso.2021.03.239. Epub 2021 Mar 16.
3
Initial clinical experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in signet-ring cell gastric cancer with peritoneal metastases.
J Gastric Cancer. 2014 Jun;14(2):117-22. doi: 10.5230/jgc.2014.14.2.117. Epub 2014 Jun 30.
4
Are positron emission tomography-computed tomography (PET-CT) scans useful in preoperative assessment of patients with peritoneal disease before cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)?
Int J Hyperthermia. 2018 Aug;34(5):524-531. doi: 10.1080/02656736.2017.1366554. Epub 2017 Aug 31.
5
Concerning CT features predict outcome of treatment in patients with malignant peritoneal mesothelioma.
Eur J Surg Oncol. 2021 Sep;47(9):2212-2219. doi: 10.1016/j.ejso.2021.04.012. Epub 2021 Apr 14.
6
Concerning CT features used to select patients for treatment of peritoneal metastases, a pictoral essay.
Int J Hyperthermia. 2017 Aug;33(5):497-504. doi: 10.1080/02656736.2017.1317368.
7
Peritoneal metastases from colorectal cancer in the absence of lymph node metastases show a high survival rate despite unfavorable prognostic indicators.
Eur J Surg Oncol. 2022 Jul;48(7):1619-1625. doi: 10.1016/j.ejso.2022.02.001. Epub 2022 Feb 3.
8
Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.
Ann Surg Oncol. 2019 Feb;26(2):482-489. doi: 10.1245/s10434-018-6860-4. Epub 2018 Dec 11.
9
Accuracy of radiologic- laparoscopic peritoneal carcinomatosis categorization in the prediction of surgical outcome.
Br J Radiol. 2019 Aug;92(1100):20190163. doi: 10.1259/bjr.20190163. Epub 2019 May 24.
10
Accuracy of whole-body diffusion-weighted MRI (WB-DWI/MRI) in diagnosis, staging and follow-up of gastric cancer, in comparison to CT: a pilot study.
BMC Med Imaging. 2021 Feb 5;21(1):18. doi: 10.1186/s12880-021-00550-2.
引用本文的文献
1
Impact of laparoscopic ultrasound during PIPAC directed treatment of unresectable peritoneal metastasis.
Pleura Peritoneum. 2024 Sep 6;9(3):107-112. doi: 10.1515/pp-2024-0007. eCollection 2024 Sep.
2
The role of multimodality imaging in the selection and management of patients treated with cytoreductive surgery and HIPEC.
Abdom Radiol (NY). 2024 Dec;49(12):4352-4364. doi: 10.1007/s00261-024-04441-2. Epub 2024 Jul 8.
3
Detection of Residual Peritoneal Metastases Following Cytoreductive Surgery Using Pegsitacianine, a pH-Sensitive Imaging Agent: Final Results from a Phase II Study.
Ann Surg Oncol. 2024 Jul;31(7):4726-4734. doi: 10.1245/s10434-024-15165-4. Epub 2024 Apr 15.
4
Extent of Disease on Visceral Peritoneal Surfaces of Mucinous Appendiceal Neoplasms Controls Survival.
Ann Surg Open. 2022 Sep 7;3(3):e193. doi: 10.1097/AS9.0000000000000193. eCollection 2022 Sep.
5
Paul Sugarbaker and Peritoneal Surface Oncology in India.
Indian J Surg Oncol. 2023 Jun;14(Suppl 1):5-6. doi: 10.1007/s13193-023-01764-2. Epub 2023 Apr 29.
6
Selection Factors for Treatment and Stratification of Rare Abdominal or Pelvic Tumors with Peritoneal Metastases.
Indian J Surg Oncol. 2023 Jun;14(Suppl 1):7-14. doi: 10.1007/s13193-022-01593-9. Epub 2022 Jul 30.
7
Current Trends in Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Peritoneal Disease from Appendiceal and Colorectal Malignancies.
J Clin Med. 2022 May 18;11(10):2840. doi: 10.3390/jcm11102840.
8
Radiologist Checklist for Selecting Patients to Undergo PIPAC (Pressurized IntraPeritoneal Aerosol Chemotherapy).
Life (Basel). 2021 Sep 9;11(9):941. doi: 10.3390/life11090941.
9
Deep Convolutional Neural Network Based on Computed Tomography Images for the Preoperative Diagnosis of Occult Peritoneal Metastasis in Advanced Gastric Cancer.
Front Oncol. 2020 Nov 2;10:601869. doi: 10.3389/fonc.2020.601869. eCollection 2020.
10
Peritoneal carcinomatosis of unknown primary site may be an undiagnosed appendiceal adenocarcinoma. A case series.
Int J Surg Case Rep. 2019;63:65-68. doi: 10.1016/j.ijscr.2019.09.005. Epub 2019 Sep 18.
本文引用的文献
1
Preoperative computed tomography does not predict resectability in peritoneal carcinomatosis.
Am J Surg. 2014 May;207(5):760-4; discussion 764-5. doi: 10.1016/j.amjsurg.2013.12.024. Epub 2014 Mar 12.
2
Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis.
Ann Surg Oncol. 2014 Aug;21(8):2608-14. doi: 10.1245/s10434-014-3647-0. Epub 2014 Mar 26.
3
Outcome data of patients with peritoneal carcinomatosis from gastric origin treated by a strategy of bidirectional chemotherapy prior to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single specialized center in Japan.
Ann Surg Oncol. 2014 Apr;21(4):1147-52. doi: 10.1245/s10434-013-3443-2. Epub 2013 Dec 20.
4
Aggressive locoregional surgical therapy for gastric peritoneal carcinomatosis.
Ann Surg Oncol. 2014 May;21(5):1448-55. doi: 10.1245/s10434-013-3327-5. Epub 2013 Nov 7.
5
Comparison of prognostic scores for patients with colorectal cancer peritoneal metastases treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Ann Surg Oncol. 2013 Dec;20(13):4183-9. doi: 10.1245/s10434-013-3204-2. Epub 2013 Aug 22.
6
Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival.
Gastroenterol Res Pract. 2012;2012:163284. doi: 10.1155/2012/163284. Epub 2012 Jul 26.
7
Evaluation of preoperative computed tomography in estimating peritoneal cancer index in peritoneal carcinomatosis.
Gan To Kagaku Ryoho. 2011 Nov;38(12):2060-4.
8
Neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal dissemination.
Ann Surg Oncol. 2011 Dec;18(13):3726-31. doi: 10.1245/s10434-011-1770-8. Epub 2011 May 17.
9
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.
Ann Surg Oncol. 2011 Jun;18(6):1575-81. doi: 10.1245/s10434-011-1631-5. Epub 2011 Mar 23.
10
Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study.
J Clin Oncol. 2010 Jan 1;28(1):63-8. doi: 10.1200/JCO.2009.23.9285. Epub 2009 Nov 16.
Zotero 插件